Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US

nork Bharmal, Murtuza, Kearney, Mairead, Zheng, Ying, Phatak, Hemant
Argitaratua izan da Clinicoecon Outcomes Res (2019)

Validation of the post sleep questionnaire for assessing subjects with restless legs syndrome: results from two double-blind, multicenter, placebo-controlled clinical trials

nork Bharmal Murtuza, Bhanegaonkar Abhijeet, Canafax Daniel M, Calloway Michael
Argitaratua 2011-04-01

Validation of the post sleep questionnaire for assessing subjects with restless legs syndrome: results from two double-blind, multicenter, placebo-controlled clinical trials

nork Canafax, Daniel M, Bhanegaonkar, Abhijeet, Bharmal, Murtuza, Calloway, Michael
Argitaratua 2011

What is the Impact of the Analysis Method Used for Health State Utility Values on QALYs in Oncology? A Simulation Study Comparing Progression-Based and Time-to-Death Approaches

nork Hatswell, Anthony J., Bullement, Ash, Schlichting, Michael, Bharmal, Murtuza
Argitaratua izan da Appl Health Econ Health Policy (2020)

Trends in CNS Prescribing Following the Economic Slowdown

nork Cascade, Elisa, Kalali, Amir H., Kwentus, Joseph A., Bharmal, Murtuza
Argitaratua 2009

Update on the psychometric properties and minimal important difference (MID) thresholds of the FACT-M questionnaire for use in treatment-naïve and previously treated patients with...

nork Bharmal, Murtuza, Nolte, Sandra, Henry-Szatkowski, Mickaël, Hennessy, Meliessa, Schlichting, Michael
Argitaratua izan da Health Qual Life Outcomes (2020)

Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection

nork Bullement, Ash, Willis, Anna, Amin, Amerah, Schlichting, Michael, Hatswell, Anthony James, Bharmal, Murtuza
Argitaratua izan da BMC Med Res Methodol (2020)

How to address the challenges of evaluating treatment benefits-risks in rare diseases? A convergent mixed methods approach applied within a Merkel cell carcinoma phase 2 clinical t...

nork Bharmal, Murtuza, Guillemin, Isabelle, Marrel, Alexia, Arnould, Benoit, Lambert, Jérémy, Hennessy, Meliessa, Fofana, Fatoumata
Argitaratua izan da Orphanet J Rare Dis (2018)

Living with Merkel Cell Carcinoma (MCC): Development of a Conceptual Model of MCC Based on Patient Experiences

nork Kaufman, Howard L., Dias Barbosa, Carla, Guillemin, Isabelle, Lambert, Jérémy, Mahnke, Lisa, Bharmal, Murtuza
Argitaratua izan da Patient (2018)

Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma

nork Nghiem, Paul, Kaufman, Howard L, Bharmal, Murtuza, Mahnke, Lisa, Phatak, Hemant, Becker, Jürgen C
Argitaratua izan da Future Oncol (2017)

Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab

nork Lanitis, Tereza, Proskorovsky, Irina, Ambavane, Apoorva, Hunger, Matthias, Zheng, Ying, Bharmal, Murtuza, Phatak, Hemant
Argitaratua izan da Adv Ther (2019)

Budget Impact Of Including Avelumab As A Second-Line Treatment For Locally Advanced Or Metastatic Urothelial Cancer In The United States: Commercial And Medicare Payer Perspectives

nork Kongnakorn, Thitima, Bharmal, Murtuza, Kearney, Mairead, Phatak, Hemant, Benedict, Agnes, Bhanegaonkar, Abhijeet, Galsky, Matthew
Argitaratua izan da Clinicoecon Outcomes Res (2019)

Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications

nork Bharmal, Murtuza, Payne, Krista, Atkinson, Mark J, Desrosiers, Marie-Pierre, Morisky, Donald E, Gemmen, Eric
Argitaratua 2009

Psychometric properties of the FACT-M questionnaire in patients with Merkel cell carcinoma

nork Bharmal, Murtuza, Fofana, Fatoumata, Barbosa, Carla Dias, Williams, Paul, Mahnke, Lisa, Marrel, Alexia, Schlichting, Michael
Argitaratua izan da Health Qual Life Outcomes (2017)

Correction to: Psychometric properties of the FACT-M questionnaire in patients with Merkel cell carcinoma

nork Bharmal, Murtuza, Fofana, Fatoumata, Barbosa, Carla Dias, Williams, Paul, Mahnke, Lisa, Marrel, Alexia, Schlichting, Michael
Argitaratua izan da Health Qual Life Outcomes (2019)

Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma

nork Bullement, Ash, Nathan, Paul, Willis, Anna, Amin, Amerah, Lilley, Cameron, Stapelkamp, Ceilidh, Hatswell, Anthony, Pescott, Chris, Bharmal, Murtuza
Argitaratua izan da Pharmacoecon Open (2019)

Treatment Sequencing Patterns in Patients with Metastatic Urothelial Cancer Treated in the Community Practice Setting in the United States: SPEAR-Bladder (Study informing treatment...

nork Doshi, Gurjyot K, Bhanegaonkar, Abhijeet, Kearney, Mairead, Bharmal, Murtuza, Cislo, Paul, Kim, Ruth, Boyd, Marley, Aguilar, Kathleen M, Phatak, Hemant
Argitaratua izan da Clinicoecon Outcomes Res (2020)

Patient Experiences with Avelumab in Treatment-Naïve Metastatic Merkel Cell Carcinoma: Longitudinal Qualitative Interview Findings from JAVELIN Merkel 200, a Registrational Clinica...

nork Lambert, Jérémy, Marrel, Alexia, D’Angelo, Sandra P., Burgess, Melissa A., Chmielowski, Bartosz, Fazio, Nicola, Gambichler, Thilo, Grob, Jean-Jacques, Lebbé, Céleste, Robert, Caroline, Russell, Jeffrey, Güzel, Gülseren, Bharmal, Murtuza
Argitaratua izan da Patient (2020)

Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe

nork Becker, Jürgen C., Lorenz, Eva, Ugurel, Selma, Eigentler, Thomas K., Kiecker, Felix, Pföhler, Claudia, Kellner, Ivonne, Meier, Friedegund, Kähler, Katharina, Mohr, Peter, Berking, Carola, Haas, Gabriele, Helwig, Christoph, Oksen, Dina, Schadendorf, Dirk, Mahnke, Lisa, Bharmal, Murtuza
Argitaratua izan da Oncotarget (2017)

Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma

nork D’Angelo, Sandra P., Hunger, Matthias, Brohl, Andrew S., Nghiem, Paul, Bhatia, Shailender, Hamid, Omid, Mehnert, Janice M., Terheyden, Patrick, Shih, Kent C., Brownell, Isaac, Lebbé, Céleste, Lewis, Karl D., Linette, Gerald P., Milella, Michele, Schlichting, Michael, Hennessy, Meliessa H., Bharmal, Murtuza
Argitaratua izan da Cancer Immunol Immunother (2019)